Dr. David Fajgenbaum, M.D

NPI: 1376513630
Total Payments
$44,867
2023 Payments
$3,400
Companies
7
Transactions
19

Payment Breakdown by Category

Consulting$35,940 (80.1%)
Other$6,620 (14.8%)
Travel$2,236 (5.0%)
Food & Beverage$71.11 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $35,940 5 80.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,400 1 7.6%
Honoraria $3,220 1 7.2%
Travel and Lodging $2,236 8 5.0%
Food and Beverage $71.11 4 0.2%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $20,000 2 $0 (2022)
Ipsen Biopharmaceuticals, Inc $12,180 1 $0 (2021)
Sobi, Inc $4,036 5 $0 (2019)
Regeneron Pharmaceuticals, Inc. $3,831 4 $0 (2018)
Spark Therapeutics, Inc. $3,400 1 $0 (2023)
Zimmer Biomet Holdings, Inc. $1,341 5 $0 (2018)
Janssen Research & Development, LLC $79.20 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $3,400 1 Spark Therapeutics, Inc. ($3,400)
2022 $5,000 1 Takeda Pharmaceuticals U.S.A., Inc. ($5,000)
2021 $27,180 2 Takeda Pharmaceuticals U.S.A., Inc. ($15,000)
2019 $4,036 5 Sobi, Inc ($4,036)
2018 $5,252 10 Regeneron Pharmaceuticals, Inc. ($3,831)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/05/2023 Spark Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,400.00 General
05/25/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $5,000.00 General
10/22/2021 Ipsen Biopharmaceuticals, Inc Consulting Fee Cash or cash equivalent $12,180.00 General
09/10/2021 Takeda Pharmaceuticals U.S.A., Inc. EXKIVITY (Drug) Consulting Fee Cash or cash equivalent $15,000.00 General
Category: ONCOLOGY
05/09/2019 Sobi, Inc Gamifant (Drug) Consulting Fee Cash or cash equivalent $2,350.00 General
Category: Hematology
04/17/2019 Sobi, Inc Gamifant (Drug) Travel and Lodging Cash or cash equivalent $169.88 General
Category: Hematology
04/16/2019 Sobi, Inc Gamifant (Drug) Travel and Lodging Cash or cash equivalent $69.00 General
Category: Hematology
04/15/2019 Sobi, Inc Gamifant (Drug) Food and Beverage In-kind items and services $36.77 General
Category: Hematology
03/27/2019 Sobi, Inc Gamifant (Drug) Consulting Fee Cash or cash equivalent $1,410.00 General
Category: Hematology
12/15/2018 Janssen Research & Development, LLC Travel and Lodging In-kind items and services $79.20 General
07/24/2018 Zimmer Biomet Holdings, Inc. Persona (Device) Food and Beverage In-kind items and services $20.25 General
Category: Knees
07/19/2018 Zimmer Biomet Holdings, Inc. Persona (Device) Travel and Lodging In-kind items and services $1,287.00 General
Category: Knees
07/19/2018 Zimmer Biomet Holdings, Inc. Persona (Device) Travel and Lodging In-kind items and services $20.00 General
Category: Knees
07/19/2018 Zimmer Biomet Holdings, Inc. Persona (Device) Food and Beverage In-kind items and services $5.00 General
Category: Knees
07/18/2018 Zimmer Biomet Holdings, Inc. Persona (Device) Food and Beverage In-kind items and services $9.09 General
Category: Knees
03/02/2018 Regeneron Pharmaceuticals, Inc. Honoraria Cash or cash equivalent $3,220.00 General
03/02/2018 Regeneron Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $192.78 General
03/02/2018 Regeneron Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $11.38 General
01/16/2018 Regeneron Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $407.00 General

About Dr. David Fajgenbaum, M.D

Dr. David Fajgenbaum, M.D is a Orthopaedic Surgery healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376513630.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Fajgenbaum, M.D has received a total of $44,867 in payments from pharmaceutical and medical device companies, with $3,400 received in 2023. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($35,940).

Practice Information

  • Specialty Orthopaedic Surgery
  • Location Raleigh, NC
  • Active Since 01/26/2006
  • Last Updated 03/18/2008
  • Taxonomy Code 207X00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1376513630

Products in Payments

  • EXKIVITY (Drug) $15,000
  • Gamifant (Drug) $4,036
  • Persona (Device) $1,341

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Orthopaedic Surgery Doctors in Raleigh